CD206 and dust particles are prognostic biomarkers of progressive fibrosing interstitial lung disease associated with air pollutant exposure

Current management strategies for progressive fibrosing interstitial lung disease (PF-ILD) and non-PF-ILD differ significantly, underscoring the need for early identification of PF-ILD patients. We analyzed the expression of macrophage markers and the number of dust particles (DP) in lung tissue, as well as complete blood count and blood chemistry tests to identify biomarkers of PF-ILD, and examined the effect of certain pollutants on these biomarkers. Lung biopsies were collected from 73 non-PF-ILD patients and 36 PF-ILD patients. DP were quantified in alveolar wall cells (DP-aw) and desquamated epithelial cells (DP-desq) using polarizing light microscopy. Expression of CD206, transforming growth factor β1 (TGF-β1), connective tissue growth factor (CTGF), C-X-C motif ligand 13 (CXCL13), fibroblast growth factor 2 (FGF-2), tumor necrosis factor α (TNFα), and interleukin 1β (IL-1β) was assessed in lung tissue by immunohistochemistry. The numbers of DP-desq, pulmonary expression of CXCL13, IL-1β and CD206 were higher in ILD patients resided for ≥ 15 days per year in places with 24-hour ambient PM<sub>10</sub> level of ≥ 50 µg/m<sup>3</sup> compared with ILD patients exposed for < 15 days per year to the similar PM<sub>10</sub> concentration. Additionally, CXCL13 expression in lung tissue was higher in smoking ILD patients than in non-smoking ILD patients. Compared with non-PF-ILD patients, PF-ILD patients exhibited higher numbers of DP-aw and DP-desq, as well as increased expression of CD206, CXCL13, IL-1β, TGF-β1, and CTGF in lung tissue. Elevated blood neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios were also observed in PF-ILD patients. These biomarkers were found to be independent predictors of PF-ILD. A regression logistic model incorporating NLR, CD206, and DP-desq predicted PF-ILD with an AUC of 0.847, sensitivity of 84.6%, and specificity of 83.3%. Our findings may be useful in predicting PF-ILD and highlight the need for reducing pollutant emission.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-03-20
DOI
https://doi.org/10.1038/s41598-025-93221-z
Citations
2
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD206 and dust particles are prognostic biomarkers of progressive fibrosing interstitial lung disease associated with air pollutant exposure

Xiaoming Cai, Е. I. Davidovskaya, V.V. Dziadzichkina, Aliaksei Kadushkin et al.
2 citations
Scientific Reports
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
3.04
article

CD206 and dust particles are prognostic biomarkers of progressive fibrosing interstitial lung disease associated with air pollutant exposure

Xiaoming Cai, Е. I. Davidovskaya, V.V. Dziadzichkina, Aliaksei Kadushkin, Olga Yudina, Nastassia Lukashevich, Vasyl Filanyuk
article en
2 citations

Abstract

Current management strategies for progressive fibrosing interstitial lung disease (PF-ILD) and non-PF-ILD differ significantly, underscoring the need for early identification of PF-ILD patients. We analyzed the expression of macrophage markers and the number of dust particles (DP) in lung tissue, as well as complete blood count and blood chemistry tests to identify biomarkers of PF-ILD, and examined the effect of certain pollutants on these biomarkers. Lung biopsies were collected from 73 non-PF-ILD patients and 36 PF-ILD patients. DP were quantified in alveolar wall cells (DP-aw) and desquamated epithelial cells (DP-desq) using polarizing light microscopy. Expression of CD206, transforming growth factor β1 (TGF-β1), connective tissue growth factor (CTGF), C-X-C motif ligand 13 (CXCL13), fibroblast growth factor 2 (FGF-2), tumor necrosis factor α (TNFα), and interleukin 1β (IL-1β) was assessed in lung tissue by immunohistochemistry. The numbers of DP-desq, pulmonary expression of CXCL13, IL-1β and CD206 were higher in ILD patients resided for ≥ 15 days per year in places with 24-hour ambient PM<sub>10</sub> level of ≥ 50 µg/m<sup>3</sup> compared with ILD patients exposed for < 15 days per year to the similar PM<sub>10</sub> concentration. Additionally, CXCL13 expression in lung tissue was higher in smoking ILD patients than in non-smoking ILD patients. Compared with non-PF-ILD patients, PF-ILD patients exhibited higher numbers of DP-aw and DP-desq, as well as increased expression of CD206, CXCL13, IL-1β, TGF-β1, and CTGF in lung tissue. Elevated blood neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte ratios were also observed in PF-ILD patients. These biomarkers were found to be independent predictors of PF-ILD. A regression logistic model incorporating NLR, CD206, and DP-desq predicted PF-ILD with an AUC of 0.847, sensitivity of 84.6%, and specificity of 83.3%. Our findings may be useful in predicting PF-ILD and highlight the need for reducing pollutant emission.

Scientific ReportsVol. 15(1)
Soochow University (CN), Republican Scientific and Practical Centre of Pulmonology and Tuberculosis (BY), RSPC MT (BY), Republican Scientific and Practical Center of Neurology and Neurosurgery (BY), Belarusian State Medical University (BY)
Good health and well-being
Openalex Percentile: Top 10%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.